Join
Live feed
·
INSIDERFilingvia Quantisnow
GenMark Diagnostics, Inc. logo

SEC Form 4: Michael Kagnoff was granted 6,880 units of Common Stock, increasing ownership by 5% to 137,319 units

ByQuantisnow·Wall Street's wire, on your screen.
GNMK· GenMark Diagnostics, Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GNMK (GenMark Diagnostics, Inc.) and more on Quantisnow.